# Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-Experienced HIV1 Infected Adults

> **NCT00090077** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 50 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** GW695634

## Key facts

- **NCT ID:** NCT00090077
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 50 (—)
- **Last updated:** 2006-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00090077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00090077, "Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-Experienced HIV1 Infected Adults". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00090077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*